Novartis AG (NVS)
FDA Applications
Note: This list only includes applications that have been responded to by the FDA.
Application | Product Name | Active Ingredient | Form | Strength | Status | ||
---|---|---|---|---|---|---|---|
BLA761349 - NOVARTIS PHARMS CORP | |||||||
COSENTYX | SECUKINUMAB | INJECTABLE;INJECTION | 150MG | Prescription | |||
BLA761128 - NOVARTIS PHARMS CORP | |||||||
ADAKVEO | CRIZANLIZUMAB-TMCA | INJECTABLE; INJECTION | 100MG/10ML | Prescription | |||
BLA761125 - NOVARTIS PHARMS CORP | |||||||
BEOVU | brolucizumab-dbll | INJECTABLE; INTRAVITREAL | 6MG/0.05ML | Prescription | |||
NDA218591 - NOVARTIS | |||||||
ENTRESTO SPRINKLE | SACUBITRIL; VALSARTAN | CAPSULE, PELLETS;ORAL | 6MG;6MG | Prescription | |||
ENTRESTO SPRINKLE | SACUBITRIL; VALSARTAN | CAPSULE, PELLETS;ORAL | 15MG;16MG | Prescription | |||
NDA218466 - NOVARTIS | |||||||
VIJOICE | ALPELISIB | GRANULES;ORAL | 50MG/PACKET | Prescription | |||
NDA218276 - NOVARTIS | |||||||
FABHALTA | IPTACOPAN HYDROCHLORIDE | CAPSULE;ORAL | EQ 200MG BASE | Prescription | |||
NDA217514 - NOVARTIS | |||||||
TAFINLAR | DABRAFENIB MESYLATE | TABLET, FOR SUSPENSION;ORAL | EQ 10MG BASE | Prescription | |||
TAFINLAR | DABRAFENIB MESYLATE | CAPSULE;ORAL | 75MG | Prescription | |||
TAFINLAR | DABRAFENIB MESYLATE | TABLET; ORAL SUSPENSION | 10MG | Prescription | |||
NDA217513 - NOVARTIS | |||||||
MEKINIST | TRAMETINIB DIMETHYL SULFOXIDE | SOLUTION;ORAL | EQ 0.05MG BASE/ML | Prescription | |||
MEKINIST | TRAMETINIB | TABLET;ORAL | 2MG | Prescription | |||
MEKINIST | TRAMETINIB | SOLUTION;ORAL | 4.7MG | Prescription | |||
NDA215841 - NOVARTIS | |||||||
LOCAMETZ | GALLIUM GA-68 GOZETOTIDE | POWDER;INTRAVENOUS | N/A | Prescription | |||
NDA215833 - NOVARTIS | |||||||
PLUVICTO | LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN | SOLUTION;INTRAVENOUS | 27mCi/ML | Prescription | |||
NDA215358 - NOVARTIS | |||||||
SCEMBLIX | ASCIMINIB HYDROCHLORIDE | TABLET;ORAL | EQ 20MG BASE | Prescription | |||
SCEMBLIX | ASCIMINIB HYDROCHLORIDE | TABLET;ORAL | EQ 40MG BASE | Prescription | |||
SCEMBLIX | ASCIMINIB HYDROCHLORIDE | TABLET;ORAL | EQ 100MG BASE | Prescription | |||
NDA215039 - NOVARTIS | |||||||
VIJOICE | ALPELISIB | TABLET;ORAL | 50MG | Prescription | |||
VIJOICE | ALPELISIB | TABLET;ORAL | 125MG | Prescription | |||
VIJOICE | ALPELISIB | TABLET;ORAL | 200MG | Prescription | |||
NDA214012 - NOVARTIS | |||||||
LEQVIO | INCLISIRAN SODIUM | SOLUTION;SUBCUTANEOUS | EQ 284MG BASE/1.5ML (EQ 189MG BASE/ML) | Prescription | |||
NDA213591 - NOVARTIS PHARM | |||||||
TABRECTA | CAPMATINIB HYDROCHLORIDE | TABLET;ORAL | EQ 150MG BASE | Prescription | |||
TABRECTA | CAPMATINIB HYDROCHLORIDE | TABLET;ORAL | EQ 200MG BASE | Prescription | |||
NDA212526 - NOVARTIS | |||||||
PIQRAY | ALPELISIB | TABLET;ORAL | 50MG | Prescription | |||
PIQRAY | ALPELISIB | TABLET;ORAL | 200MG | Prescription | |||
PIQRAY | ALPELISIB | TABLET;ORAL | 150MG | Prescription | |||
NDA211225 - NOVARTIS | |||||||
ZYKADIA | CERITINIB | TABLET;ORAL | 150MG | Prescription | |||
NDA209935 - NOVARTIS | |||||||
KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | TABLET;ORAL | 2.5MG;EQ 200MG BASE | Prescription | |||
NDA209884 - NOVARTIS | |||||||
MAYZENT | SIPONIMOD | TABLET;ORAL | EQ 0.25MG BASE | Prescription | |||
MAYZENT | SIPONIMOD | TABLET;ORAL | EQ 2MG BASE | Prescription | |||
MAYZENT | SIPONIMOD | TABLET;ORAL | EQ 1MG BASE | Prescription | |||
NDA209092 - NOVARTIS | |||||||
KISQALI | RIBOCICLIB SUCCINATE | TABLET;ORAL | EQ 200MG BASE | Prescription | |||
NDA208711 - NOVARTIS | |||||||
EGATEN | TRICLABENDAZOLE | TABLET;ORAL | 250MG | Prescription | |||
NDA207997 - NOVARTIS | |||||||
RYDAPT | MIDOSTAURIN | CAPSULE;ORAL | 25MG | Prescription | |||
NDA207968 - NOVARTIS | |||||||
JADENU SPRINKLE | DEFERASIROX | GRANULE;ORAL | 360MG | Prescription | |||
JADENU SPRINKLE | DEFERASIROX | GRANULE;ORAL | 180MG | Prescription | |||
JADENU SPRINKLE | DEFERASIROX | GRANULE;ORAL | 90MG | Prescription | |||
NDA207930 - NOVARTIS | |||||||
UTIBRON | GLYCOPYRROLATE; INDACATEROL MALEATE | POWDER;INHALATION | 15.6MCG/INH;27.5MCG/INH | Discontinued | |||
NDA207923 - NOVARTIS | |||||||
SEEBRI | GLYCOPYRROLATE | POWDER;INHALATION | 15.6MCG/INH | Discontinued | |||
NDA207620 - NOVARTIS PHARMS CORP | |||||||
ENTRESTO | SACUBITRIL; VALSARTAN | TABLET;ORAL | 24MG;26MG | Prescription | |||
ENTRESTO | SACUBITRIL; VALSARTAN | TABLET;ORAL | 97MG;103MG | Prescription | |||
ENTRESTO | SACUBITRIL; VALSARTAN | TABLET;ORAL | 49MG;51MG | Prescription | |||
NDA207027 - NOVARTIS | |||||||
PROMACTA KIT | ELTROMBOPAG OLAMINE | FOR SUSPENSION;ORAL | EQ 25MG ACID/PACKET | Prescription | |||
PROMACTA KIT | ELTROMBOPAG OLAMINE | FOR SUSPENSION;ORAL | EQ 12.5MG ACID/PACKET | Prescription | |||
NDA206910 - NOVARTIS PHARMS CORP | |||||||
JADENU | DEFERASIROX | TABLET;ORAL | 360MG | Prescription | |||
JADENU | DEFERASIROX | TABLET;ORAL | 180MG | Prescription | |||
JADENU | DEFERASIROX | TABLET;ORAL | 90MG | Prescription | |||
NDA205755 - NOVARTIS | |||||||
ZYKADIA | CERITINIB | CAPSULE;ORAL | 150MG | Discontinued | |||
NDA204822 - NOVARTIS | |||||||
IZBA | TRAVOPROST | SOLUTION/DROPS;OPHTHALMIC | 0.003% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA204114 - NOVARTIS | |||||||
MEKINIST | TRAMETINIB DIMETHYL SULFOXIDE | TABLET;ORAL | EQ 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
MEKINIST | TRAMETINIB DIMETHYL SULFOXIDE | TABLET;ORAL | EQ 0.5MG | Prescription | |||
MEKINIST | TRAMETINIB DIMETHYL SULFOXIDE | TABLET;ORAL | EQ 2MG | Prescription | |||
NDA203985 - NOVARTIS PHARM | |||||||
AFINITOR DISPERZ | EVEROLIMUS | TABLET, FOR SUSPENSION;ORAL | 2MG | Prescription | |||
AFINITOR DISPERZ | EVEROLIMUS | TABLET, FOR SUSPENSION;ORAL | 3MG | Prescription | |||
AFINITOR DISPERZ | EVEROLIMUS | TABLET, FOR SUSPENSION;ORAL | 5MG | Prescription | |||
NDA202806 - NOVARTIS | |||||||
TAFINLAR | DABRAFENIB MESYLATE | CAPSULE;ORAL | EQ 75MG BASE | Prescription | |||
TAFINLAR | DABRAFENIB MESYLATE | CAPSULE;ORAL | EQ 50MG BASE | Prescription | |||
NDA200045 - NOVARTIS | |||||||
AMTURNIDE | ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE | TABLET;ORAL | EQ 150MG BASE;EQ 5MG BASE;12.5MG | Discontinued | |||
AMTURNIDE | ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE | TABLET;ORAL | EQ 300MG BASE;EQ 5MG BASE;12.5MG | Discontinued | |||
AMTURNIDE | ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE | TABLET;ORAL | EQ 300MG BASE;EQ 5MG BASE;25MG | Discontinued | |||
AMTURNIDE | ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE | TABLET;ORAL | EQ 300MG BASE;EQ 10MG BASE;12.5MG | Discontinued | |||
AMTURNIDE | ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE | TABLET;ORAL | EQ 300MG BASE;EQ 10MG BASE;25MG | Discontinued | |||
BLA125504 - NOVARTIS PHARMS CORP | |||||||
COSENTYX | SECUKINUMAB | INJECTABLE;INJECTION | 150MG/ML | Prescription | |||
BLA125326 - NOVARTIS | |||||||
ARZERRA | OFATUMUMAB | INJECTABLE; INJECTION | 100MG/5ML | Prescription | |||
KESIMPTA | OFATUMUMAB | SOLUTION;SUBCUTANEOUS | 20MG/0.4ML | Prescription | |||
BLA125319 - NOVARTIS PHARMS | |||||||
ILARIS | CANAKINUMAB | INJECTABLE; SUBCUTANEOUS | 180MG | Prescription | |||
BLA103764 - NOVARTIS | |||||||
SIMULECT | BASILIXIMAB | VIAL; SINGLE-USE | 10MG | Prescription | |||
SIMULECT | BASILIXIMAB | VIAL; SINGLE-USE | 20MG | Prescription | |||
ANDA089047 - NOVARTIS | |||||||
SULF-15 | SULFACETAMIDE SODIUM | SOLUTION/DROPS;OPHTHALMIC | 15% | Discontinued | |||
ANDA088791 - NOVARTIS | |||||||
VASOCIDIN | PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM | OINTMENT;OPHTHALMIC | 0.5%;10% | Discontinued | |||
ANDA086765 - NOVARTIS | |||||||
IMIPRAMINE HYDROCHLORIDE | IMIPRAMINE HYDROCHLORIDE | CONCENTRATE;ORAL | 25MG/ML | Discontinued | |||
ANDA085148 - NOVARTIS | |||||||
ASBRON | THEOPHYLLINE SODIUM GLYCINATE | TABLET;ORAL | EQ 150MG BASE | Discontinued | |||
ANDA084811 - NOVARTIS | |||||||
APRESAZIDE | HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE | CAPSULE;ORAL | 100MG;50MG | Discontinued | |||
ANDA084810 - NOVARTIS | |||||||
APRESAZIDE | HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE | CAPSULE;ORAL | 50MG;50MG | Discontinued | |||
ANDA084735 - NOVARTIS | |||||||
APRESAZIDE | HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE | CAPSULE;ORAL | 25MG;25MG | Discontinued | |||
ANDA083149 - NOVARTIS | |||||||
PBZ | TRIPELENNAMINE HYDROCHLORIDE | TABLET;ORAL | 25MG | Discontinued | |||
ANDA080935 - NOVARTIS | |||||||
INH | ISONIAZID | TABLET;ORAL | 300MG | Discontinued | |||
ANDA080751 - NOVARTIS | |||||||
INFLAMASE MILD | PREDNISOLONE SODIUM PHOSPHATE | SOLUTION/DROPS;OPHTHALMIC | EQ 0.11% PHOSPHATE | Discontinued | |||
INFLAMASE FORTE | PREDNISOLONE SODIUM PHOSPHATE | SOLUTION/DROPS;OPHTHALMIC | EQ 0.9% PHOSPHATE | Discontinued | |||
ANDA080235 - NOVARTIS | |||||||
VASOCON | NAPHAZOLINE HYDROCHLORIDE | SOLUTION/DROPS;OPHTHALMIC | 0.1% | Discontinued | |||
ANDA080025 - NOVARTIS | |||||||
SULF-10 | SULFACETAMIDE SODIUM | SOLUTION/DROPS;OPHTHALMIC | 10% | Discontinued | |||
ANDA074857 - NOVARTIS | |||||||
TRIAMTERENE AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; TRIAMTERENE | CAPSULE;ORAL | 25MG;37.5MG | Discontinued | |||
ANDA073677 - NOVARTIS | |||||||
CARBASTAT | CARBACHOL | SOLUTION;INTRAOCULAR | 0.01% | Discontinued | |||
ANDA072687 - NOVARTIS | |||||||
FOAMICON | ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE | TABLET, CHEWABLE;ORAL | 80MG;20MG | Discontinued | |||
ANDA070185 - NOVARTIS | |||||||
FLUOR-OP | FLUOROMETHOLONE | SUSPENSION/DROPS;OPHTHALMIC | 0.1% | Discontinued | |||
ANDA062566 - NOVARTIS | |||||||
DEXACIDIN | DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE | OINTMENT;OPHTHALMIC | 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM | Discontinued | |||
ANDA062544 - NOVARTIS | |||||||
DEXACIDIN | DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE | SUSPENSION/DROPS;OPHTHALMIC | 0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML | Discontinued | |||
ANDA062501 - NOVARTIS | |||||||
GENTACIDIN | GENTAMICIN SULFATE | OINTMENT;OPHTHALMIC | EQ 0.3% BASE | Discontinued | |||
ANDA062480 - NOVARTIS | |||||||
GENTACIDIN | GENTAMICIN SULFATE | SOLUTION/DROPS;OPHTHALMIC | EQ 0.3% BASE | Discontinued | |||
NDA050791 - NOVARTIS | |||||||
MYFORTIC | MYCOPHENOLIC SODIUM | TABLET, DELAYED RELEASE;ORAL | EQ 180MG BASE | Prescription | |||
MYFORTIC | MYCOPHENOLIC SODIUM | TABLET, DELAYED RELEASE;ORAL | EQ 360MG BASE | Prescription | |||
NDA050738 - NOVARTIS | |||||||
NEORAL | CYCLOSPORINE | CAPSULE; ORAL | 25MG | Prescription | |||
NEORAL | CYCLOSPORINE | CAPSULE; ORAL | 100MG | Prescription | |||
NDA050737 - NOVARTIS | |||||||
NEORAL | CYCLOSPORINE | CAPSULE; ORAL | 25MG | Prescription | |||
NEORAL | CYCLOSPORINE | CAPSULE; ORAL | 100MG | Prescription | |||
NDA050736 - NOVARTIS | |||||||
NEORAL | CYCLOSPORINE | CAPSULE; ORAL | 100MG | Prescription | |||
NEORAL | CYCLOSPORINE | CAPSULE; ORAL | 25MG | Prescription | |||
NDA050735 - NOVARTIS | |||||||
NEORAL | CYCLOSPORINE | CAPSULE; ORAL | 25MG | Prescription | |||
NEORAL | CYCLOSPORINE | CAPSULE; ORAL | 100MG | Prescription | |||
NDA050716 - NOVARTIS | |||||||
NEORAL | CYCLOSPORINE | SOLUTION;ORAL | 100MG/ML | Prescription | |||
NDA050715 - NOVARTIS | |||||||
NEORAL | CYCLOSPORINE | CAPSULE;ORAL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NEORAL | CYCLOSPORINE | CAPSULE;ORAL | 100MG | Prescription | |||
NEORAL | CYCLOSPORINE | CAPSULE;ORAL | 25MG | Prescription | |||
NDA050625 - NOVARTIS | |||||||
SANDIMMUNE | CYCLOSPORINE | CAPSULE;ORAL | 50MG | Prescription | |||
SANDIMMUNE | CYCLOSPORINE | CAPSULE;ORAL | 100MG | Prescription | |||
SANDIMMUNE | CYCLOSPORINE | CAPSULE;ORAL | 25MG | Prescription | |||
NDA050616 - NOVARTIS | |||||||
TOBRADEX | DEXAMETHASONE; TOBRAMYCIN | OINTMENT;OPHTHALMIC | 0.1%;0.3% | Prescription | |||
NDA050574 - NOVARTIS | |||||||
SANDIMMUNE | CYCLOSPORINE | SOLUTION;ORAL | 100MG/ML | Prescription | |||
NDA050573 - NOVARTIS | |||||||
SANDIMMUNE | CYCLOSPORINE | INJECTABLE;INJECTION | 50MG/ML | Prescription | |||
NDA050555 - NOVARTIS | |||||||
TOBREX | TOBRAMYCIN | OINTMENT;OPHTHALMIC | 0.3% | Prescription | |||
NDA050541 - NOVARTIS | |||||||
TOBREX | TOBRAMYCIN | SOLUTION/DROPS;OPHTHALMIC | 0.3% | Discontinued | |||
NDA022545 - NOVARTIS | |||||||
TEKAMLO | ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE | TABLET;ORAL | EQ 150MG BASE;EQ 5MG BASE | Discontinued | |||
TEKAMLO | ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE | TABLET;ORAL | EQ 150MG BASE;EQ 10MG BASE | Discontinued | |||
TEKAMLO | ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE | TABLET;ORAL | EQ 300MG BASE;EQ 5MG BASE | Discontinued | |||
TEKAMLO | ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE | TABLET;ORAL | EQ 300MG BASE;EQ 10MG BASE | Discontinued | |||
NDA022527 - NOVARTIS | |||||||
GILENYA | FINGOLIMOD HYDROCHLORIDE | CAPSULE;ORAL | EQ 0.25MG BASE | Prescription | |||
GILENYA | FINGOLIMOD HYDROCHLORIDE | CAPSULE;ORAL | EQ 0.5MG BASE | Prescription | |||
NDA022470 - NOVARTIS | |||||||
NEXCEDE | KETOPROFEN | FILM;ORAL | 12.5MG | Discontinued | |||
NDA022465 - NOVARTIS | |||||||
VOTRIENT | PAZOPANIB HYDROCHLORIDE | TABLET;ORAL | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
VOTRIENT | PAZOPANIB HYDROCHLORIDE | TABLET;ORAL | EQ 200MG BASE | Prescription | |||
NDA022383 - NOVARTIS | |||||||
ARCAPTA NEOHALER | INDACATEROL MALEATE | POWDER;INHALATION | EQ 75MCG BASE | Discontinued | |||
NDA022334 - NOVARTIS | |||||||
AFINITOR | EVEROLIMUS | TABLET;ORAL | 10MG | Prescription | |||
AFINITOR | EVEROLIMUS | TABLET;ORAL | 2.5MG | Prescription | |||
AFINITOR | EVEROLIMUS | TABLET;ORAL | 5MG | Prescription | |||
AFINITOR | EVEROLIMUS | TABLET;ORAL | 7.5MG | Prescription | |||
NDA022314 - NOVARTIS | |||||||
EXFORGE HCT | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | EQ 5MG BASE;12.5MG;160MG | Prescription | |||
EXFORGE HCT | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | EQ 5MG BASE;25MG;160MG | Prescription | |||
EXFORGE HCT | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | EQ 10MG BASE;12.5MG;160MG | Prescription | |||
EXFORGE HCT | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | EQ 10MG BASE;25MG;160MG | Prescription | |||
EXFORGE HCT | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | EQ 10MG BASE;25MG;320MG | Prescription | |||
NDA022291 - NOVARTIS | |||||||
PROMACTA | ELTROMBOPAG OLAMINE | TABLET;ORAL | EQ 25MG ACID | Prescription | |||
PROMACTA | ELTROMBOPAG OLAMINE | TABLET;ORAL | EQ 50MG ACID | Prescription | |||
PROMACTA | ELTROMBOPAG OLAMINE | TABLET;ORAL | EQ 100MG ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
PROMACTA | ELTROMBOPAG OLAMINE | TABLET;ORAL | EQ 75MG ACID | Prescription | |||
PROMACTA | ELTROMBOPAG OLAMINE | TABLET;ORAL | EQ 12.5MG ACID | Prescription | |||
NDA022268 - NOVARTIS | |||||||
COARTEM | ARTEMETHER; LUMEFANTRINE | TABLET;ORAL | 20MG;120MG | Prescription | |||
NDA022217 - NOVARTIS | |||||||
VALTURNA | ALISKIREN HEMIFUMARATE; VALSARTAN | TABLET;ORAL | EQ 150MG BASE;160MG | Discontinued | |||
VALTURNA | ALISKIREN HEMIFUMARATE; VALSARTAN | TABLET;ORAL | EQ 300MG BASE;320MG | Discontinued | |||
NDA022154 - NOVARTIS | |||||||
TYZEKA | TELBIVUDINE | SOLUTION;ORAL | 100MG/5ML | Discontinued | |||
NDA022071 - NOVARTIS | |||||||
LAMISIL | TERBINAFINE HYDROCHLORIDE | GRANULE;ORAL | EQ 125MG BASE/PACKET | Discontinued | |||
LAMISIL | TERBINAFINE HYDROCHLORIDE | GRANULE;ORAL | EQ 187.5MG BASE/PACKET | Discontinued | |||
NDA022068 - NOVARTIS | |||||||
TASIGNA | NILOTINIB HYDROCHLORIDE | CAPSULE;ORAL | EQ 200MG BASE | Prescription | |||
TASIGNA | NILOTINIB HYDROCHLORIDE | CAPSULE;ORAL | EQ 50MG BASE | Prescription | |||
TASIGNA | NILOTINIB HYDROCHLORIDE | CAPSULE;ORAL | EQ 150MG BASE | Prescription | |||
NDA022059 - NOVARTIS | |||||||
TYKERB | LAPATINIB DITOSYLATE | TABLET;ORAL | EQ 250MG BASE | Prescription | |||
NDA022011 - NOVARTIS | |||||||
TYZEKA | TELBIVUDINE | TABLET;ORAL | 600MG | Discontinued | |||
NDA021990 - NOVARTIS | |||||||
EXFORGE | AMLODIPINE BESYLATE; VALSARTAN | TABLET;ORAL | EQ 5MG BASE;320MG | Prescription | |||
EXFORGE | AMLODIPINE BESYLATE; VALSARTAN | TABLET;ORAL | EQ 10MG BASE;320MG | Prescription | |||
EXFORGE | AMLODIPINE BESYLATE; VALSARTAN | TABLET;ORAL | EQ 5MG BASE;160MG | Prescription | |||
EXFORGE | AMLODIPINE BESYLATE; VALSARTAN | TABLET;ORAL | EQ 10MG BASE;160MG | Prescription | |||
NDA021882 - NOVARTIS | |||||||
EXJADE | DEFERASIROX | TABLET, FOR SUSPENSION;ORAL | 125MG | Prescription | |||
EXJADE | DEFERASIROX | TABLET, FOR SUSPENSION;ORAL | 250MG | Prescription | |||
EXJADE | DEFERASIROX | TABLET, FOR SUSPENSION;ORAL | 500MG | Prescription | |||
NDA021861 - NOVARTIS | |||||||
PATANASE | OLOPATADINE HYDROCHLORIDE | SPRAY, METERED;NASAL | 0.665MG/SPRAY | Discontinued | |||
NDA021592 - NOVARTIS | |||||||
FORADIL CERTIHALER | FORMOTEROL FUMARATE | POWDER;INHALATION | 0.0085MG/INH | Discontinued | |||
NDA021588 - NOVARTIS | |||||||
GLEEVEC | IMATINIB MESYLATE | TABLET;ORAL | EQ 100MG BASE | Prescription | |||
GLEEVEC | IMATINIB MESYLATE | TABLET;ORAL | EQ 400MG BASE | Prescription | |||
NDA021560 - NOVARTIS | |||||||
ZORTRESS | EVEROLIMUS | TABLET;ORAL | 0.25MG | Prescription | |||
ZORTRESS | EVEROLIMUS | TABLET;ORAL | 0.75MG | Prescription | |||
ZORTRESS | EVEROLIMUS | TABLET;ORAL | 1MG | Prescription | |||
ZORTRESS | EVEROLIMUS | TABLET;ORAL | 0.5MG | Prescription | |||
NDA021386 - NOVARTIS | |||||||
ZOMETA | ZOLEDRONIC ACID | INJECTABLE; IV (INFUSION) | EQ 4MG BASE/VIAL | Prescription | |||
NDA021335 - NOVARTIS | |||||||
GLEEVEC | IMATINIB MESYLATE | CAPSULE;ORAL | EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
GLEEVEC | IMATINIB MESYLATE | CAPSULE;ORAL | EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA021285 - NOVARTIS | |||||||
TRILEPTAL | OXCARBAZEPINE | SUSPENSION;ORAL | 300MG/5ML | Prescription | |||
NDA021283 - NOVARTIS | |||||||
DIOVAN | VALSARTAN | TABLET;ORAL | 40MG | Prescription | |||
DIOVAN | VALSARTAN | TABLET;ORAL | 320MG | Prescription | |||
DIOVAN | VALSARTAN | TABLET;ORAL | 160MG | Prescription | |||
DIOVAN | VALSARTAN | TABLET;ORAL | 80MG | Prescription | |||
NDA021279 - NOVARTIS | |||||||
FORADIL | FORMOTEROL FUMARATE | POWDER; INHALATION | 0.012MG/INH | Discontinued | |||
NDA021223 - NOVARTIS | |||||||
ZOMETA | ZOLEDRONIC ACID | INJECTABLE;INTRAVENOUS | EQ 4MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
ZOMETA | ZOLEDRONIC ACID | INJECTABLE;INTRAVENOUS | EQ 4MG BASE/100ML | Discontinued | |||
ZOMETA | ZOLEDRONIC ACID | INJECTABLE;INTRAVENOUS | EQ 4MG BASE/5ML | Discontinued | |||
NDA021204 - NOVARTIS | |||||||
STARLIX | NATEGLINIDE | TABLET;ORAL | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
STARLIX | NATEGLINIDE | TABLET;ORAL | 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA021167 - NOVARTIS | |||||||
VIVELLE | ESTRADIOL | FILM, EXTENDED RELEASE; TRANSDERMAL | 0.0375MG/24HR | Discontinued | |||
VIVELLE | ESTRADIOL | FILM, EXTENDED RELEASE; TRANSDERMAL | 0.05MG/24HR | Prescription | |||
VIVELLE | ESTRADIOL | FILM, EXTENDED RELEASE; TRANSDERMAL | 0.075MG/24HR | Discontinued | |||
VIVELLE | ESTRADIOL | FILM, EXTENDED RELEASE; TRANSDERMAL | 0.025MG/24HR | Discontinued | |||
VIVELLE | ESTRADIOL | FILM, EXTENDED RELEASE; TRANSDERMAL | 0.1MG/24HR | Prescription | |||
NDA021082 - NOVARTIS | |||||||
TAVIST ALLERGY/SINUS/HEADACHE | ACETAMINOPHEN; CLEMASTINE FUMARATE; PSEUDOEPHEDRINE HYDROCHLORIDE | TABLET;ORAL | 500MG;EQ 0.25MG BASE;30MG | Discontinued | |||
NDA021025 - NOVARTIS | |||||||
EXELON | RIVASTIGMINE TARTRATE | SOLUTION;ORAL | EQ 2MG BASE/ML | Discontinued | |||
NDA021014 - NOVARTIS | |||||||
TRILEPTAL | OXCARBAZEPINE | TABLET;ORAL | 300MG | Prescription | |||
TRILEPTAL | OXCARBAZEPINE | TABLET;ORAL | 600MG | Prescription | |||
TRILEPTAL | OXCARBAZEPINE | TABLET;ORAL | 150MG | Prescription | |||
NDA021008 - NOVARTIS | |||||||
SANDOSTATIN LAR | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 10MG BASE/VIAL | Prescription | |||
SANDOSTATIN LAR | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 20MG BASE/VIAL | Prescription | |||
SANDOSTATIN LAR | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 30MG BASE/VIAL | Prescription | |||
NDA020961 - NOVARTIS | |||||||
VITRAVENE PRESERVATIVE FREE | FOMIVIRSEN SODIUM | INJECTABLE;INJECTION | 6.6MG/ML | Discontinued | |||
NDA020927 - NOVARTIS | |||||||
AREDIA | PAMIDRONATE DISODIUM | INJECTABLE;INJECTION | 60MG/VIAL | Prescription | |||
AREDIA | PAMIDRONATE DISODIUM | INJECTABLE; INJECTION | 90MG/VIAL | Prescription | |||
AREDIA | PAMIDRONATE DISODIUM | INJECTABLE; INJECTION | 30MG/VIAL | Prescription | |||
NDA020831 - NOVARTIS | |||||||
FORADIL | FORMOTEROL FUMARATE | POWDER;INHALATION | 0.012MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA020823 - NOVARTIS | |||||||
EXELON | RIVASTIGMINE TARTRATE | CAPSULE;ORAL | EQ 1.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
EXELON | RIVASTIGMINE TARTRATE | CAPSULE;ORAL | EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
EXELON | RIVASTIGMINE TARTRATE | CAPSULE;ORAL | EQ 4.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
EXELON | RIVASTIGMINE TARTRATE | CAPSULE;ORAL | EQ 6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA020818 - NOVARTIS | |||||||
DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | 12.5MG;80MG | Prescription | |||
DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | 12.5MG;160MG | Prescription | |||
DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | 25MG;160MG | Prescription | |||
DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | 12.5MG;320MG | Prescription | |||
DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | 25MG;320MG | Prescription | |||
NDA020726 - NOVARTIS PHARMS | |||||||
FEMARA | LETROZOLE | TABLET;ORAL | 2.5MG | Prescription | |||
NDA020706 - NOVARTIS | |||||||
EMADINE | EMEDASTINE DIFUMARATE | SOLUTION/DROPS;OPHTHALMIC | 0.05% | Discontinued | |||
NDA020665 - NOVARTIS | |||||||
DIOVAN | VALSARTAN | CAPSULE;ORAL | 160MG | Discontinued | |||
DIOVAN | VALSARTAN | CAPSULE;ORAL | 80MG | Discontinued | |||
NDA020539 - NOVARTIS | |||||||
LAMISIL | TERBINAFINE HYDROCHLORIDE | TABLET;ORAL | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA020363 - NOVARTIS | |||||||
FAMVIR | FAMCICLOVIR | TABLET;ORAL | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
FAMVIR | FAMCICLOVIR | TABLET;ORAL | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
FAMVIR | FAMCICLOVIR | TABLET;ORAL | 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA020261 - NOVARTIS | |||||||
LESCOL | FLUVASTATIN SODIUM | CAPSULE;ORAL | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
LESCOL | FLUVASTATIN SODIUM | CAPSULE;ORAL | EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA020254 - NOVARTIS | |||||||
VOLTAREN-XR | DICLOFENAC SODIUM | TABLET, EXTENDED RELEASE;ORAL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA020234 - NOVARTIS | |||||||
TEGRETOL-XR | CARBAMAZEPINE | TABLET, EXTENDED RELEASE;ORAL | 200MG | Prescription | |||
TEGRETOL-XR | CARBAMAZEPINE | TABLET, EXTENDED RELEASE;ORAL | 400MG | Prescription | |||
TEGRETOL-XR | CARBAMAZEPINE | TABLET, EXTENDED RELEASE;ORAL | 100MG | Prescription | |||
NDA020219 - NOVARTIS | |||||||
LIVOSTIN | LEVOCABASTINE HYDROCHLORIDE | SUSPENSION/DROPS;OPHTHALMIC | EQ 0.05% BASE | Discontinued | |||
NDA020192 - NOVARTIS | |||||||
LAMISIL | TERBINAFINE HYDROCHLORIDE | CREAM;TOPICAL | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA020191 - NOVARTIS | |||||||
ALOMIDE | LODOXAMIDE TROMETHAMINE | SOLUTION/DROPS;OPHTHALMIC | EQ 0.1% BASE | Prescription | |||
NDA020144 - NOVARTIS | |||||||
TRANSDERM-NITRO | NITROGLYCERIN | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.1MG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
TRANSDERM-NITRO | NITROGLYCERIN | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.2MG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
TRANSDERM-NITRO | NITROGLYCERIN | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.4MG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
TRANSDERM-NITRO | NITROGLYCERIN | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.6MG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
TRANSDERM-NITRO | NITROGLYCERIN | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.8MG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA020142 - NOVARTIS | |||||||
CATAFLAM | DICLOFENAC POTASSIUM | TABLET;ORAL | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
CATAFLAM | DICLOFENAC POTASSIUM | TABLET;ORAL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA020037 - NOVARTIS | |||||||
VOLTAREN | DICLOFENAC SODIUM | SOLUTION/DROPS;OPHTHALMIC | 0.1% | Discontinued | |||
NDA020036 - NOVARTIS | |||||||
AREDIA | PAMIDRONATE DISODIUM | INJECTABLE;INJECTION | 30MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
AREDIA | PAMIDRONATE DISODIUM | INJECTABLE;INJECTION | 90MG/VIAL | Discontinued | |||
AREDIA | PAMIDRONATE DISODIUM | INJECTABLE;INJECTION | 60MG/VIAL | Discontinued | |||
NDA019972 - NOVARTIS | |||||||
OCUPRESS | CARTEOLOL HYDROCHLORIDE | SOLUTION/DROPS;OPHTHALMIC | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA019845 - NOVARTIS | |||||||
BETOPTIC S | BETAXOLOL HYDROCHLORIDE | SUSPENSION/DROPS;OPHTHALMIC | EQ 0.25% BASE | Prescription | |||
NDA019786 - NOVARTIS | |||||||
LOPRESSOR | METOPROLOL FUMARATE | TABLET, EXTENDED RELEASE;ORAL | EQ 200MG TARTRATE | Discontinued | |||
LOPRESSOR | METOPROLOL FUMARATE | TABLET, EXTENDED RELEASE;ORAL | EQ 300MG TARTRATE | Discontinued | |||
LOPRESSOR | METOPROLOL FUMARATE | TABLET, EXTENDED RELEASE;ORAL | EQ 400MG TARTRATE | Discontinued | |||
LOPRESSOR | METOPROLOL FUMARATE | TABLET, EXTENDED RELEASE;ORAL | EQ 100MG TARTRATE | Discontinued | |||
NDA019667 - NOVARTIS | |||||||
SANDOSTATIN | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 0.1MG BASE/ML | Prescription | |||
SANDOSTATIN | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 0.5MG BASE/ML | Prescription | |||
SANDOSTATIN | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
SANDOSTATIN | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
SANDOSTATIN | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 0.05MG BASE/ML | Prescription | |||
NDA019500 - NOVARTIS | |||||||
LAMPRENE | CLOFAZIMINE | CAPSULE;ORAL | 50MG | Discontinued | |||
LAMPRENE | CLOFAZIMINE | CAPSULE;ORAL | 100MG | Discontinued | |||
NDA019451 - NOVARTIS | |||||||
LOPRESSIDONE | CHLORTHALIDONE; METOPROLOL TARTRATE | CAPSULE;ORAL | 25MG;100MG | Discontinued | |||
LOPRESSIDONE | CHLORTHALIDONE; METOPROLOL TARTRATE | CAPSULE;ORAL | 25MG;200MG | Discontinued | |||
NDA019381 - NOVARTIS | |||||||
TEN-K | POTASSIUM CHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 10MEQ | Discontinued | |||
NDA019201 - NOVARTIS | |||||||
VOLTAREN | DICLOFENAC SODIUM | TABLET, DELAYED RELEASE;ORAL | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
VOLTAREN | DICLOFENAC SODIUM | TABLET, DELAYED RELEASE;ORAL | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
VOLTAREN | DICLOFENAC SODIUM | TABLET, DELAYED RELEASE;ORAL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA019081 - NOVARTIS | |||||||
ESTRADERM | ESTRADIOL | SYSTEM;TRANSDERMAL | 0.05MG/24HR | Discontinued | |||
ESTRADERM | ESTRADIOL | SYSTEM;TRANSDERMAL | 0.1MG/24HR | Discontinued | |||
NDA018988 - NOVARTIS | |||||||
VASOCIDIN | PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM | SOLUTION/DROPS;OPHTHALMIC | EQ 0.23% PHOSPHATE;10% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA018927 - NOVARTIS | |||||||
TEGRETOL | CARBAMAZEPINE | SUSPENSION;ORAL | 100MG/5ML | Prescription | |||
NDA018885 - NOVARTIS | |||||||
EMBOLEX | DIHYDROERGOTAMINE MESYLATE; HEPARIN SODIUM; LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.5MG/0.5ML;2,500 UNITS/0.5ML;5.33MG/0.5ML | Discontinued | |||
EMBOLEX | DIHYDROERGOTAMINE MESYLATE; HEPARIN SODIUM; LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.5MG/0.7ML;5,000 UNITS/0.7ML;7.46MG/0.7ML | Discontinued | |||
NDA018872 - NOVARTIS | |||||||
VISKAZIDE | HYDROCHLOROTHIAZIDE; PINDOLOL | TABLET;ORAL | 25MG;5MG | Discontinued | |||
VISKAZIDE | HYDROCHLOROTHIAZIDE; PINDOLOL | TABLET;ORAL | 25MG;10MG | Discontinued | |||
NDA018762 - NOVARTIS | |||||||
BRETHAIRE | TERBUTALINE SULFATE | AEROSOL, METERED;INHALATION | 0.2MG/INH | Discontinued | |||
NDA018746 - NOVARTIS | |||||||
VASOCON-A | ANTAZOLINE PHOSPHATE; NAPHAZOLINE HYDROCHLORIDE | SOLUTION/DROPS;OPHTHALMIC | 0.5%;0.05% | Discontinued | |||
NDA018706 - NOVARTIS | |||||||
HYDERGINE LC | ERGOLOID MESYLATES | CAPSULE;ORAL | 1MG | Discontinued | |||
NDA018704 - NOVARTIS | |||||||
LOPRESSOR | METOPROLOL TARTRATE | INJECTABLE;INJECTION | 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA018675 - NOVARTIS | |||||||
TAVIST | CLEMASTINE FUMARATE | SYRUP;ORAL | EQ 0.5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA018470 - NOVARTIS | |||||||
CIBACALCIN | CALCITONIN HUMAN | INJECTABLE;INJECTION | 0.5MG/VIAL | Discontinued | |||
NDA018418 - NOVARTIS | |||||||
HYDERGINE | ERGOLOID MESYLATES | SOLUTION;ORAL | 1MG/ML | Discontinued | |||
NDA018285 - NOVARTIS | |||||||
VISKEN | PINDOLOL | TABLET;ORAL | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
VISKEN | PINDOLOL | TABLET;ORAL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA018281 - NOVARTIS | |||||||
TEGRETOL | CARBAMAZEPINE | TABLET, CHEWABLE;ORAL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA018245 - NOVARTIS | |||||||
SYNTOCINON | OXYTOCIN | INJECTABLE;INJECTION | 10USP UNITS/ML | Discontinued | |||
NDA018202 - NOVARTIS | |||||||
CYTADREN | AMINOGLUTETHIMIDE | TABLET;ORAL | 250MG | Discontinued | |||
NDA018166 - NOVARTIS | |||||||
TRASICOR | OXPRENOLOL HYDROCHLORIDE | CAPSULE;ORAL | 20MG | Discontinued | |||
TRASICOR | OXPRENOLOL HYDROCHLORIDE | CAPSULE;ORAL | 40MG | Discontinued | |||
TRASICOR | OXPRENOLOL HYDROCHLORIDE | CAPSULE;ORAL | 80MG | Discontinued | |||
TRASICOR | OXPRENOLOL HYDROCHLORIDE | CAPSULE;ORAL | 160MG | Discontinued | |||
NDA018115 - NOVARTIS | |||||||
TRIAMINIC-12 | CHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 12MG;75MG | Discontinued | |||
NDA018029 - NOVARTIS | |||||||
RITALIN-SR | METHYLPHENIDATE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA017993 - NOVARTIS | |||||||
HYDERGINE | ERGOLOID MESYLATES | TABLET;ORAL | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
HYDERGINE | ERGOLOID MESYLATES | TABLET;ORAL | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA017923 - NOVARTIS | |||||||
MELLARIL-S | THIORIDAZINE | SUSPENSION;ORAL | EQ 25MG HYDROCHLORIDE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
MELLARIL-S | THIORIDAZINE | SUSPENSION;ORAL | EQ 100MG HYDROCHLORIDE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA017869 - NOVARTIS | |||||||
FUNDUSCEIN-25 | FLUORESCEIN SODIUM | INJECTABLE;INJECTION | 25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA017851 - NOVARTIS | |||||||
LIORESAL | BACLOFEN | TABLET;ORAL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
LIORESAL | BACLOFEN | TABLET;ORAL | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA017661 - NOVARTIS | |||||||
TAVIST | CLEMASTINE FUMARATE | TABLET;ORAL | 2.68MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
TAVIST-1 | CLEMASTINE FUMARATE | TABLET;ORAL | 1.34MG | Discontinued | |||
TAVIST-1 | CLEMASTINE FUMARATE | TABLET;ORAL | 1.34MG | Discontinued | |||
NDA017543 - NOVARTIS | |||||||
LUDIOMIL | MAPROTILINE HYDROCHLORIDE | TABLET;ORAL | 25MG | Discontinued | |||
LUDIOMIL | MAPROTILINE HYDROCHLORIDE | TABLET;ORAL | 50MG | Discontinued | |||
LUDIOMIL | MAPROTILINE HYDROCHLORIDE | TABLET;ORAL | 75MG | Discontinued | |||
NDA017476 - NOVARTIS | |||||||
SLOW-K | POTASSIUM CHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 8MEQ | Discontinued | |||
NDA017247 - NOVARTIS | |||||||
SANOREX | MAZINDOL | TABLET;ORAL | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
SANOREX | MAZINDOL | TABLET;ORAL | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA016997 - NOVARTIS | |||||||
SERENTIL | MESORIDAZINE BESYLATE | CONCENTRATE;ORAL | EQ 25MG BASE/ML | Discontinued | |||
NDA016775 - NOVARTIS | |||||||
SERENTIL | MESORIDAZINE BESYLATE | INJECTABLE;INJECTION | EQ 25MG BASE/ML | Discontinued | |||
NDA016774 - NOVARTIS | |||||||
SERENTIL | MESORIDAZINE BESYLATE | TABLET;ORAL | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
SERENTIL | MESORIDAZINE BESYLATE | TABLET;ORAL | EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
SERENTIL | MESORIDAZINE BESYLATE | TABLET;ORAL | EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
SERENTIL | MESORIDAZINE BESYLATE | TABLET;ORAL | EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA016755 - NOVARTIS | |||||||
DIAPID | LYPRESSIN | SOLUTION;NASAL | 0.185MG/ML | Discontinued | |||
NDA016608 - NOVARTIS | |||||||
TEGRETOL | CARBAMAZEPINE | TABLET;ORAL | 200MG | Prescription | |||
NDA016379 - NOVARTIS | |||||||
LOCORTEN | FLUMETHASONE PIVALATE | CREAM;TOPICAL | 0.03% | Discontinued | |||
NDA016267 - NOVARTIS | |||||||
DESFERAL | DEFEROXAMINE MESYLATE | INJECTABLE;INJECTION | 500MG/VIAL | Prescription | |||
DESFERAL | DEFEROXAMINE MESYLATE | INJECTABLE;INJECTION | 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA016211 - NOVARTIS | |||||||
MIOCHOL | ACETYLCHOLINE CHLORIDE | FOR SOLUTION;OPHTHALMIC | 20MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA013553 - NOVARTIS | |||||||
ESIMIL | GUANETHIDINE MONOSULFATE; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 10MG;25MG | Discontinued | |||
NDA013420 - NOVARTIS | |||||||
TREST | METHIXENE HYDROCHLORIDE | TABLET;ORAL | 1MG | Discontinued | |||
NDA013247 - NOVARTIS | |||||||
TORECAN | THIETHYLPERAZINE MALEATE | SUPPOSITORY;RECTAL | 10MG | Discontinued | |||
NDA012754 - NOVARTIS | |||||||
TORECAN | THIETHYLPERAZINE MALATE | INJECTABLE;INJECTION | 5MG/ML | Discontinued | |||
NDA012753 - NOVARTIS | |||||||
TORECAN | THIETHYLPERAZINE MALEATE | TABLET;ORAL | 10MG | Discontinued | |||
NDA012542 - NOVARTIS | |||||||
TANDEARIL | OXYPHENBUTAZONE | TABLET;ORAL | 100MG | Discontinued | |||
NDA012516 - NOVARTIS | |||||||
SANSERT | METHYSERGIDE MALEATE | TABLET;ORAL | 2MG | Discontinued | |||
NDA012329 - NOVARTIS | |||||||
ISMELIN | GUANETHIDINE MONOSULFATE | TABLET;ORAL | EQ 10MG SULFATE | Discontinued | |||
ISMELIN | GUANETHIDINE MONOSULFATE | TABLET;ORAL | EQ 25MG SULFATE | Discontinued | |||
NDA012193 - NOVARTIS | |||||||
SER-AP-ES | HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE | TABLET;ORAL | 25MG;15MG;0.1MG | Discontinued | |||
NDA012026 - NOVARTIS | |||||||
APRESOLINE-ESIDRIX | HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 25MG;15MG | Discontinued | |||
NDA011878 - NOVARTIS | |||||||
SERPASIL-ESIDRIX #1 | HYDROCHLOROTHIAZIDE; RESERPINE | TABLET;ORAL | 25MG;0.1MG | Discontinued | |||
SERPASIL-ESIDRIX #2 | HYDROCHLOROTHIAZIDE; RESERPINE | TABLET;ORAL | 50MG;0.1MG | Discontinued | |||
NDA011838 - NOVARTIS | |||||||
TOFRANIL | IMIPRAMINE HYDROCHLORIDE | INJECTABLE;INJECTION | 12.5MG/ML | Discontinued | |||
NDA011808 - NOVARTIS | |||||||
MELLARIL | THIORIDAZINE HYDROCHLORIDE | TABLET;ORAL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
MELLARIL | THIORIDAZINE HYDROCHLORIDE | TABLET;ORAL | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
MELLARIL | THIORIDAZINE HYDROCHLORIDE | TABLET;ORAL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
MELLARIL | THIORIDAZINE HYDROCHLORIDE | TABLET;ORAL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
MELLARIL | THIORIDAZINE HYDROCHLORIDE | CONCENTRATE;ORAL | 30MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
MELLARIL | THIORIDAZINE HYDROCHLORIDE | TABLET;ORAL | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
MELLARIL | THIORIDAZINE HYDROCHLORIDE | TABLET;ORAL | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
MELLARIL | THIORIDAZINE HYDROCHLORIDE | TABLET;ORAL | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
MELLARIL | THIORIDAZINE HYDROCHLORIDE | CONCENTRATE;ORAL | 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA011793 - NOVARTIS | |||||||
ESIDRIX | HYDROCHLOROTHIAZIDE | TABLET;ORAL | 25MG | Discontinued | |||
ESIDRIX | HYDROCHLOROTHIAZIDE | TABLET;ORAL | 50MG | Discontinued | |||
ESIDRIX | HYDROCHLOROTHIAZIDE | TABLET;ORAL | 100MG | Discontinued | |||
NDA011556 - NOVARTIS | |||||||
ANTURANE | SULFINPYRAZONE | TABLET;ORAL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
ANTURANE | SULFINPYRAZONE | CAPSULE;ORAL | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA010533 - NOVARTIS | |||||||
PBZ-SR | TRIPELENNAMINE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 100MG | Discontinued | |||
PBZ-SR | TRIPELENNAMINE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 50MG | Discontinued | |||
NDA009436 - NOVARTIS | |||||||
ACYLANID | ACETYLDIGITOXIN | TABLET;ORAL | 0.1MG | Discontinued | |||
NDA009434 - NOVARTIS | |||||||
SERPASIL | RESERPINE | INJECTABLE;INJECTION | 2.5MG/ML | Discontinued | |||
NDA009296 - NOVARTIS | |||||||
SERPASIL-APRESOLINE | HYDRALAZINE HYDROCHLORIDE; RESERPINE | TABLET;ORAL | 50MG;0.2MG | Discontinued | |||
SERPASIL-APRESOLINE | HYDRALAZINE HYDROCHLORIDE; RESERPINE | TABLET;ORAL | 25MG;0.1MG | Discontinued | |||
NDA009282 - NOVARTIS | |||||||
CEDILANID-D | DESLANOSIDE | INJECTABLE;INJECTION | 0.2MG/ML | Discontinued | |||
NDA009215 - NOVARTIS | |||||||
RAUTENSIN | ALSEROXYLON | TABLET;ORAL | 2MG | Discontinued | |||
NDA009115 - NOVARTIS | |||||||
SERPASIL | RESERPINE | TABLET;ORAL | 0.1MG | Discontinued | |||
SERPASIL | RESERPINE | TABLET;ORAL | 0.25MG | Discontinued | |||
SERPASIL | RESERPINE | TABLET;ORAL | 1MG | Discontinued | |||
SERPASIL | RESERPINE | ELIXIR;ORAL | 0.2MG/4ML | Discontinued | |||
NDA009087 - NOVARTIS | |||||||
HYDERGINE | ERGOLOID MESYLATES | TABLET;SUBLINGUAL | 0.5MG | Discontinued | |||
HYDERGINE | ERGOLOID MESYLATES | TABLET;SUBLINGUAL | 1MG | Discontinued | |||
NDA009000 - NOVARTIS | |||||||
CAFERGOT | CAFFEINE; ERGOTAMINE TARTRATE | SUPPOSITORY;RECTAL | 100MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA008822 - NOVARTIS | |||||||
PERCORTEN | DESOXYCORTICOSTERONE PIVALATE | INJECTABLE;INJECTION | 25MG/ML | Discontinued | |||
NDA008492 - NOVARTIS | |||||||
ANTRENYL | OXYPHENONIUM BROMIDE | TABLET;ORAL | 5MG | Discontinued | |||
NDA008319 - NOVARTIS | |||||||
BUTAZOLIDIN | PHENYLBUTAZONE | TABLET;ORAL | 100MG | Discontinued | |||
BUTAZOLIDIN | PHENYLBUTAZONE | CAPSULE;ORAL | 100MG | Discontinued | |||
NDA008303 - NOVARTIS | |||||||
APRESOLINE | HYDRALAZINE HYDROCHLORIDE | TABLET;ORAL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
APRESOLINE | HYDRALAZINE HYDROCHLORIDE | TABLET;ORAL | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
APRESOLINE | HYDRALAZINE HYDROCHLORIDE | TABLET;ORAL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
APRESOLINE | HYDRALAZINE HYDROCHLORIDE | INJECTABLE;INJECTION | 20MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
APRESOLINE | HYDRALAZINE HYDROCHLORIDE | TABLET;ORAL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA008278 - NOVARTIS | |||||||
REGITINE | PHENTOLAMINE MESYLATE | INJECTABLE;INJECTION | 5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA006620 - NOVARTIS | |||||||
CAFERGOT | CAFFEINE; ERGOTAMINE TARTRATE | TABLET;ORAL | 100MG;1MG | Discontinued | |||
NDA006403 - NOVARTIS | |||||||
PRISCOLINE | TOLAZOLINE HYDROCHLORIDE | INJECTABLE;INJECTION | 25MG/ML | Discontinued | |||
NDA006203 - NOVARTIS | |||||||
HEAVY SOLUTION NUPERCAINE | DIBUCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 2.5MG/ML | Discontinued | |||
NDA006008 - NOVARTIS | |||||||
MESANTOIN | MEPHENYTOIN | TABLET;ORAL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA005914 - NOVARTIS | |||||||
PBZ | TRIPELENNAMINE HYDROCHLORIDE | TABLET;ORAL | 50MG | Discontinued | |||
PBZ | TRIPELENNAMINE CITRATE | ELIXIR;ORAL | EQ 25MG HYDROCHLORIDE/5ML | Discontinued | |||
NDA005151 - NOVARTIS | |||||||
PERCORTEN | DESOXYCORTICOSTERONE ACETATE | PELLET;IMPLANTATION | 125MG | Discontinued | |||
NDA003240 - NOVARTIS | |||||||
METANDREN | METHYLTESTOSTERONE | TABLET;BUCCAL, SUBLINGUAL | 10MG | Discontinued | |||
METANDREN | METHYLTESTOSTERONE | TABLET;BUCCAL, SUBLINGUAL | 25MG | Discontinued | |||
METANDREN | METHYLTESTOSTERONE | TABLET;BUCCAL, SUBLINGUAL | 5MG | Discontinued | |||
METANDREN | METHYLTESTOSTERONE | TABLET;BUCCAL, SUBLINGUAL | 10MG | Discontinued |